Edap TMS SA (EDAP)

2.68
0.01 0.37
NASDAQ : Health Care
Prev Close 2.69
Open 2.65
Day Low/High 2.51 / 2.68
52 Wk Low/High 2.76 / 6.57
Volume 36.88K
Avg Volume 114.90K
Exchange NASDAQ
Shares Outstanding 28.73M
Market Cap 77.28M
EPS 0.10
P/E Ratio 20.69
Div & Yield N.A. (N.A)

Latest News

EDAP-TMS To Announce Second Quarter 2017 Financial Results On Wednesday, August 23, 2017

EDAP Announces Filing Of 510(k) Application For Ablatherm-Fusion® Device
EDAP To Host Webcast Discussing HIFU Devices With An American Key Opinion Leader

EDAP To Host Webcast Discussing HIFU Devices With An American Key Opinion Leader

EDAP Announces Withdrawal Of 510(k) Application For Focal One® To Be Followed By New Submission To Conform To FDA Review Rules

EDAP Announces Withdrawal Of 510(k) Application For Focal One® To Be Followed By New Submission To Conform To FDA Review Rules

EDAP Announces CMS Approval Of New Reimbursement Code For HIFU Ablation Of The Prostate

EDAP TMS SA Reports First Quarter 2017 Results

EDAP Announces Ablatherm Fusion World Premiere During American Urology Association Annual Meeting In Boston, MA, May 12-16, 2017

EDAP TMS SA To Report First Quarter 2017 Financial Results On May 17, 2017

EDAP Achieves 63% Growth In HIFU Revenue In 2016

EDAP's Ablatherm® Robotic HIFU: Clinical Results Support High-Intensity Focused Ultrasound (HIFU) For Prostate Tissue Ablation After Unsuccessful Radiotherapy

EDAP TMS SA To Report Fourth Quarter And Full Year 2016 Results On April 3, 2017

EDAP's Long Term Academic HIFU Partner INSERM LabTAU Designated Center Of Excellence By The Focused Ultrasound Foundation

EDAP Appoints Vice-President Of Global Medical, Regulatory And Quality Affairs In The U.S.

EDAP's Ablatherm® Robotic HIFU Treatments Performed At University Of Minnesota

EDAP Announces Preliminary Unaudited Full Year 2016 Revenue

EDAP To Exclusively Distribute LABORIE's Medical Measurement Systems Urodynamic Products In Japan

EDAP To Exclusively Distribute LABORIE's Medical Measurement Systems Urodynamic Products In Japan

EDAP To Host Meetings With Investors During JP Morgan Healthcare Conference Week

EDAP To Host Meetings With Investors During JP Morgan Healthcare Conference Week

EDAP Reports Superior Outcomes Of Focal Ablatherm-HIFU Compared To Robotic Radical Prostatectomy

EDAP Reports Superior Outcomes Of Focal Ablatherm-HIFU Compared To Robotic Radical Prostatectomy

Similar Cancer Control at 5 Years, Significantly Less Incidence of Incontinence and Erectile Dysfunction

EDAP Announces Focal One® HIFU Sale To Foch Hospital, Paris

EDAP Announces Focal One® HIFU Sale To Foch Hospital, Paris

Growing Adoption of Focal One HIFU in France

EDAP TMS Retains CG Capital As New Investor Relations Counsel

EDAP TMS Retains CG Capital As New Investor Relations Counsel

EDAP Receives The Prestigious Prix Galien For Its Focal One® HIFU Device

EDAP Receives The Prestigious Prix Galien For Its Focal One® HIFU Device

EDAP Achieves 79% Growth In HIFU Revenue For First Nine Months Of 2016

EDAP Achieves 79% Growth In HIFU Revenue For First Nine Months Of 2016

EDAP To Report Third Quarter 2016 Financial Results On November 17, 2016

EDAP To Report Third Quarter 2016 Financial Results On November 17, 2016

Conference Call and Webcast Scheduled for 8:30 a.m. ET

EDAP's Ablatherm® Robotic HIFU Positioned As Efficient Option For Unilateral Prostate Ablation In Breakthrough Multicenter Study Published In Major Medical Journal

EDAP's Ablatherm® Robotic HIFU Positioned As Efficient Option For Unilateral Prostate Ablation In Breakthrough Multicenter Study Published In Major Medical Journal

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AMS, ASUR, EDAP Downgrades: ACSF, AG, ASYS, INFO Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

EDAP Installs Ablatherm Robotic® HIFU At Leading Academic Medical Center

EDAP Installs Ablatherm Robotic® HIFU At Leading Academic Medical Center

EDAP TMS To Present At The 18th Annual Rodman And Renshaw Global Investment Conference

EDAP TMS To Present At The 18th Annual Rodman And Renshaw Global Investment Conference

EDAP Reports 69% Growth In HIFU Revenues And Operating Profit For First Half 2016

EDAP Reports 69% Growth In HIFU Revenues And Operating Profit For First Half 2016

EDAP's Ablatherm® Robotic HIFU Treats First Patient At Henry Ford Hospital In Detroit

EDAP's Ablatherm® Robotic HIFU Treats First Patient At Henry Ford Hospital In Detroit

EDAP To Report Second Quarter 2016 Financial Results On August 25, 2016

EDAP To Report Second Quarter 2016 Financial Results On August 25, 2016

Conference Call and Webcast Scheduled for 8:30 a.m. ET

Load More
Quant Rating on 3:59 PM EDT 8/18/2017

C

(Hold)

From Our Partners

Masimo (MASI) Introduces SafetyNet System in Dubai Hospitals
Zacks

athenahealth (ATHN) Shares Rally on Earnings Beat in Q2
Zacks

Intuitive Surgical (ISRG) Beats on Q2 Earnings & Revenues
Zacks

AngioDynamics (ANGO) Shares Down Despite Q4 Earnings Beat
Zacks

Stryker Poised on Solid Product Portfolio and Acquisitions
Zacks

Accuray's Q4 Preliminary Results Fail to Cheer Investors
Zacks

EDAP withdraws U.S. marketing application for Focal One, resubmission planned with new clinical data
SeekingAlpha

Accuray's Medical Systems to be Acquired by Dubai Hospital
Zacks

McKesson (MCK) Poised on Improving Generic and Brand Market
Zacks

Masimo (MASI) Rainbow Super DCI-mini Sensor Now CE Marked
Zacks

Fresenius Medical (FMS) Well Poised on Growth Strategy 2020
Zacks

Becton, Dickinson (BDX) Poised on C.R. Bard Acquisition
Zacks

Mazor Expects Higher Q2 Revenues, Wins Mazor X Orders
Zacks

Envision Healthcare Rallies on Infinity Healthcare Buyout
Zacks

Exactech (EXAC) Launches Application for Knee Replacement
Zacks
TheStreet Quant Rating: C (Hold)

Get the (EDAP)
Report Here

Trending
Cisco's Chuck Robbins Says Tech's Diversity Problem 'Should Be a Nonissue'
An Epic Stock Market Crash Is Coming, Veteran Forecaster Peter Schiff Warns
A Nation of Broke People Are Killing Retail More Than Amazon: Top Expert
Foot Locker Obliterated - Here Are 30 of Nike's Most Iconic and Expensive Sneaks
Gap is Extremely Excited About Stretch Pants